{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:02:07Z","timestamp":1788372127310,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Preventive drugs for stress ulcers are widely and unreasonably used in the Intensive Care Unit (ICU). This study aims to examine the appropriate utilization of medications for stress ulcer prophylaxis (SUP) and identify factors that contribute to the inappropriate use of these medications in the ICU of the Second Hospital of Shanxi Medical University.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patient cases admitted to the ICU during the period from May 2022 to May 2023 were extracted from the hospital\u2019s information management system. Single-factor analysis and multivariate logistic regression model analysis were performed using the SPSS to identify factors associated with inappropriate medication for prophylaxis. The efficacy of this predictive model was assessed through the use of the Receiver Operating Characteristic Curve (ROC), while the Hosmer test was utilized to evaluate the model fit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included a total of 651 patient cases that met the inclusion criteria. Among these cases, 48.39% were found to have received inappropriate medication of SUP. The analysis revealed a significant association between inappropriate medication and partial transfer to departments (P &amp;lt; 0.05), as well as the use of anticoagulants (P = 0.009) in the prophylaxis group. In the non-prophylaxis group, the multifactorial logistic analysis indicated a significant correlation between inadequate prescriptions and partial transfer to departments (P &amp;lt; 0.05), as well as the presence of artificial airways (P &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is a notable prevalence of inappropriate SUP in the ICU of this hospital. Attention should be paid to the SUP of some patients transferred to the department, the use of anticoagulants and the presence of artificial airway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1401335","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:31:42Z","timestamp":1736227902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit"],"prefix":"10.3389","volume":"15","author":[{"given":"Pan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naobei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5414\/cp202533","article-title":"Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan","volume":"54","author":"Alqudah","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","article-title":"ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP board of directors on november 14, 1998","volume":"56","year":"1999","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7504\/cjps.issn1005-2208.2015.07.10","article-title":"Prevention and treatment of stress mucosal lesions-consensus of Chinese general surgery experts (2015)","volume":"35","author":"Association","year":"2015","journal-title":"Chin. J. Pract. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.5009\/gnl16568","article-title":"Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis","volume":"11","author":"Azab","year":"2017","journal-title":"Gut Liver"},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrgastro.2014.235","article-title":"Stress-related mucosal disease in the critically ill patient","volume":"12","author":"Bardou","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ajg.2011.474","article-title":"Proton pump inhibitors vs. Histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis","volume":"107","author":"Barkun","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40273-013-0119-5","article-title":"Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences","volume":"32","author":"Barletta","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3760\/cma.j.issn.0376-2491.2018.42.003","article-title":"Consensus review for stress ulcer prophylaxis and treatment","volume":"98","author":"Bo","year":"2018","journal-title":"Natl. Med. J. China"},{"key":"B9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00535-019-01652-z","article-title":"Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden","volume":"55","author":"Brusselaers","year":"2020","journal-title":"J. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/bcp.14197","article-title":"Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients","volume":"86","author":"Choi","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.amjmed.2021.09.010","article-title":"Indications for the use of proton pump inhibitors for stress ulcer prophylaxis and peptic ulcer bleeding in hospitalized patients","volume":"135","author":"Clarke","year":"2022","journal-title":"Am. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2404245","article-title":"Stress ulcer prophylaxis during invasive mechanical ventilation","volume":"391","author":"Cook","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15887\/j.cnki.13-1389\/r.2023.36.042","article-title":"Review of proton pump inhibitor prescriptions in 2022 and analysis of irrational prescriptions in our hospital proper clinical application","volume":"16","author":"Fan","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s1441-2772(23)01783-0","article-title":"Inappropriate continuation of stress ulcer prophylaxis beyond the intensive Care setting","volume":"15","author":"Farley","year":"2013","journal-title":"Crit. Care Resusc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"w20322","DOI":"10.4414\/smw.2020.20322","article-title":"Adequacy of stress ulcer prophylaxis prescription in the intensive Care unit: an observational study","volume":"150","author":"Franchitti","year":"2020","journal-title":"Swiss Med. Wkly."},{"key":"B16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/0885066612453542","article-title":"Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive Care unit","volume":"29","author":"Frandah","year":"2014","journal-title":"J. Intensive Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/aas.12508","article-title":"Stress ulcer prophylaxis in the intensive Care unit: an international survey of 97 Units in 11 countries","volume":"59","author":"Krag","year":"2015","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/j.amjmed.2020.08.004","article-title":"Proton pump inhibitors versus histamine-2 receptor antagonists likely increase mortality in critical Care: an updated meta-analysis","volume":"134","author":"Lee","year":"2021","journal-title":"Am. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"881063","DOI":"10.3389\/fphar.2022.881063","article-title":"Appropriateness and associated factors of stress ulcer prophylaxis for surgical inpatients of orthopedics department in a tertiary hospital: a cross-sectional study","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12913-018-3358-5","article-title":"Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital","volume":"18","author":"Luo","year":"2018","journal-title":"BMC Health Serv. Res."},{"key":"B21","first-page":"C4811","article-title":"Guideline for stress ulcer prophylaxis in the intensive Care unit","volume":"61","author":"Madsen","year":"2014","journal-title":"Dan. Med. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"46958018759116","DOI":"10.1177\/0046958018759116","article-title":"A successful pharmacist-based quality initiative to reduce inappropriate stress ulcer prophylaxis use in an academic medical intensive Care unit","volume":"55","author":"Masood","year":"2018","journal-title":"Inquiry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/sga.0000000000000278","article-title":"Evaluation of adherence to American society of health-system pharmacists guidelines: stress ulcer prophylaxis in shiraz, Iran","volume":"40","author":"Masoompour","year":"2017","journal-title":"Gastroenterol. Nurs."},{"key":"B24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3748\/wjg.v16.i8.982","article-title":"Clinical and cost impact of intravenous proton pump inhibitor use in non-icu patients","volume":"16","author":"Nasser","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3969\/j.issn.1672-7185.2021.01.001","article-title":"Guiding principles for clinical application of proton pump inhibitors (2020 edition)","volume":"28","year":"2020","journal-title":"Chin. Pract. J. Rural Dr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2217\/cer-2017-0098","article-title":"Comparing efficacy of enteral nutrition plus ranitidine and enteral nutrition alone as stress ulcer prophylaxis","volume":"7","author":"Nourian","year":"2018","journal-title":"J. Comp. Eff. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s11606-020-06425-6","article-title":"Reducing inappropriate proton pump inhibitors use for stress ulcer prophylaxis in hospitalized patients: systematic review of de-implementation studies","volume":"36","author":"Orelio","year":"2021","journal-title":"J. Gen. Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12603-015-0642-5","article-title":"Inappropriate use of proton pump inhibitors in elderly patients discharged from acute Care hospitals","volume":"20","author":"Schepisi","year":"2016","journal-title":"J. Nutr. Health Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"18467","DOI":"10.1038\/s41598-021-98069-7","article-title":"Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive Care unit","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3760\/cma.j.issn.2095-4352.2019.05.004","article-title":"Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients","volume":"31","author":"Sun","year":"2019","journal-title":"Chin. Crit. Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.15403\/jgld.2014.1121.264.hra","article-title":"Ppis prevent aspirin-induced gastrointestinal bleeding better than H2ras. A systematic review and meta-analysis","volume":"26","author":"Szab\u00f3","year":"2017","journal-title":"J. Gastrointestin Liver Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"l6744","DOI":"10.1136\/bmj.l6744","article-title":"Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis","volume":"368","author":"Wang","year":"2020","journal-title":"Bmj"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0306","article-title":"Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients","volume":"30","author":"Wijaya","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12876-021-01979-z","article-title":"Physicians' knowledge, attitude, and prescribing behavior regarding stress ulcer prophylaxis in China: a multi-center study","volume":"21","author":"Xing","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"l6722","DOI":"10.1136\/bmj.l6722","article-title":"Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline","volume":"368","author":"Ye","year":"2020","journal-title":"Bmj"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4292\/wjgpt.v2.i4.27","article-title":"Stress ulcer prophylaxis guidelines: are they being implemented in Lebanese health Care centers?","volume":"2","author":"Zeitoun","year":"2011","journal-title":"World J. Gastrointest. Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1401335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:31:51Z","timestamp":1736227911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1401335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":36,"alternative-id":["10.3389\/fphar.2024.1401335"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1401335","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1401335"}}